Ivey Business School (Canada)
-
Valeant Pharmaceuticals: Eroded Reputation and Stock Price
Mary Gillett; Amy HorrocksCase IVEY-9B20B014-EAccounting and ControlIn early January 2019, a recent Ivey Business School graduate logged into her online trading account to review her portfolio’s performance. As she scanned her investments, she paused at one stock in particular. It was time to make a decision regarding one of her most volatile stocks—Valeant Pharmaceuticals International Inc., recently renamed Bausch Health Companies Inc. The pharmaceutical company was once celebrated for its innovative business a...Starting at €8.20